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Abstract
The oxytocin (OT) system, critically involved in social bonding, may also impinge on spirituality, which is the belief in a
meaningful life imbued with a sense of connection to a Higher Power and/or the world. Midlife male participants (N¼83)
were randomly assigned to receive intranasal OT or placebo. In exploratory analyses, participants were also genotyped for
polymorphisms in two genes critical for OT signaling, the oxytocin receptor gene (OXTR rs53576) and CD38 (rs6449182 and
rs3796863). Results showed that intranasal OT increased self-reported spirituality on two separate measures and this effect
remained significant a week later. It also boosted participants’ experience of specific positive emotions during meditation,
at both explicit and implicit levels. Furthermore, the effect of OT on spirituality was moderated by OT-related genotypes.
These results provide the first experimental evidence that spirituality, endorsed by millions worldwide, appears to be
supported by OT.
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Introduction
Spirituality—the belief in a meaningful life imbued with a sense
of connection to a Higher Power, the world, or both—is
endorsed by millions of people worldwide. What are the
neurochemical systems that may undergird these beliefs?
Because the oxytocin (OT) system is critically implicated in
social bonding, here, we investigate its role in supporting
spirituality.
Spirituality and OT
Based on emerging scholarly consensus (see Zinnbauer and
Pargament, 2005), here we define spirituality as one’s personal
affirmation of and relationship to a higher power or to the sa-
cred. Spirituality typically implies the belief in a life infused
with meaning and purpose, and the belief in relatedness and
interconnectedness with the world and all living beings (Van
Cappellen and Rime´, 2014).
OT is a polypeptide synthesized in the hypothalamus, which
can be released into the bloodstream as well as to the forebrain.
Peripherally, it acts as a hormone and centrally as a neuromo-
dulator affecting many regions of the brain (Lee et al., 2009). OT
has received increasing attention among social psychologists
for its implication in many social affiliative processes, such as
empathy, trust and gaze to the eye region (e.g. MacDonald and
MacDonald, 2010). At least in contexts that are not interpreted
as competitive or threatening (Olff et al., 2013), OT promotes
reduced self-focus (Liu et al., 2013), increased positive focus on
others (Bartz et al., 2011), parochial and universal altruism
(Israel et al., 2012), and extended affiliation motives (e.g. em-
pathy, even toward the pain of an outgroup; Shamay-Tsoory
et al., 2013). An open question is whether the social bonding ef-
fect of OT may extend more broadly to support the affiliative
components within spirituality’s definition. These include a
sense of connectedness with the world and all living beings or
with a Higher Power, which people tend to conceptualize as a
person and can be considered a symbolic figure of attachment
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(Granqvist and Kirkpatrick, 2013). Given the demonstrated so-
cial functions of OT, we hypothesized that OT prompts a mind-
set that supports the emergence and salience of spirituality-like
beliefs.
Two recent correlational studies support the idea that OT is
involved in spirituality. First, among 79 HIV patients, endogenous
OT (assayed from plasma) was positively correlated with two
self-report spirituality measures (i.e. one item on how spiritual
one considers himself/herself and the Ironson-Woods
Spirituality/Religiousness Index; Kelsch et al., 2013). Plasma levels
of OT were also two times higher among patients who reported a
spiritually transformative experience. Second, in a non-clinical
sample of 34 devout American Christians, endogenous OT
(assayed from saliva) was positively correlated with self-reported
spirituality (using a similar one-item measure as in Kelsch et al.,
2013), even after accounting for church attendance, positive af-
fect, gender and relationship status (Holbrook et al., 2015).
These initial correlations suggest that OT is generally related
to spirituality. However, experimental evidence is needed to
test the causal role of OT on spiritual experiences. By randomiz-
ing participants to receive OT or placebo, our first primary aim
was to investigate whether an increase in exogenous OT leads
to an increase in spirituality. In addition, we reasoned that the
boost in spirituality might lead participants to be more engaged
and immersed in an activity that is often tied to spirituality and
practiced by spiritual people, i.e. meditation. As a consequence,
participants in the OT condition would more intensely experi-
ence the positive emotions derived from engaging in medita-
tion. Therefore, our second primary aim was to test whether
during an initiation to meditation, participants who received OT
would experience greater positive emotions, especially ones
relevant to spirituality and spiritual practices, i.e. self-
transcendent positive emotions such as awe (Saroglou et al.,
2008; Van Cappellen et al., 2013).
Genetic differences in response to OT administration
Intranasal OT administration does not appear to affect everyone
uniformly (Bartz et al., 2011). Individual differences at the gen-
etic level are likely to be one factor that can moderate the psy-
chological effects of intranasal OT administration. Such effects
have been demonstrated for the most commonly studied poly-
morphism in the OT receptor gene, OXTR rs53576 (Marsh et al.,
2012; Feng et al., 2015). Therefore, in exploratory analyses we
sought to replicate this effect of rs53576 as well as extend evi-
dence of genetic moderation to the CD38 gene. CD38 is crucial
for the release of OT from hypothalamic neurons in the brain.
Accordingly, mice with the deletion of CD38 gene show pro-
found social deficits (Jin et al., 2007). In a regulatory control re-
gion (intron 1) of the human CD38 gene, there is a
polymorphism (rs6449182) that affects transcription factor bind-
ing and subsequent expression of the gene (Saborit-Villarroya
et al., 2011). Consistent with a role for OT in social bonding,
rs6449182 has been associated with social emotions (Algoe and
Way, 2014; I.S., W,O., E,R.P., B,G., Unpublished data). Another
polymorphism (rs3796863) located in a different region of CD38
(intron 7) has been linked to unextracted plasma OT levels and
social attunement (Feldman et al., 2012). In exploratory ana-
lyses, we tested whether the effect of OT administration on
spirituality would be moderated by OT polymorphisms because
this provides additional evidence of oxytocinergic involvement
in spirituality.
The present study aims to illuminate potential biological
mechanisms underlying spirituality by focusing on the OT
system. Participants were randomized to receive intranasal OT
or placebo. We hypothesized that OT, a neuropeptide critically
involved in social bonding, has a facilitative effect on spiritual-
ity beliefs and the positive emotions derived from engaging in
meditation. In exploratory analyses, we also evaluate who is
more susceptible to these effects of intranasal OT by examining
variation in genes related to OT signaling.
Materials and methods
Participants and procedure
This study was approved by the Institutional Review Board of
the first author’s institution and all participants gave written in-
formed consent. Local newspapers, websites and posted flyers
recruited mid-life adults (ages 35–64). This study is part of a
multiple study grant that specifically targeted mid-life adults,
an age during which psychological changes can be critical for
later life health. This demographic also offers more generaliz-
ability than most studies of OT administration. Exclusion crite-
ria were maintaining regular meditation practice (currently or
previously), taking antihypertensive medication and having the
ability to read Chinese pictographs (this criterion applied to an-
other task unrelated to the current investigation). The data pre-
sented here are part of a larger study testing additional
hypotheses not related to the present ones. For the larger study
and to test a larger model, based on power calculation, a sample
of 240 participants was targeted with a breakdown female–male
of 125–115 to reflect the composition of the community from
which the sample was drawn. Data collection, which occurred
from September 2013 to July 2014, stopped at 239 but despite re-
cruitment effort, the sample is skewed toward females. This re-
port focuses only on the 83 males who took part in the study,
which is a slightly higher sample size than most studies investi-
gating the psychological effects of OT among males and seems
sufficient to detect effects (recent examples: Israel et al., 2014;
Bartz et al., 2015). Growing evidence suggests that the effects of
OT are different for males and females (Feng et al., 2015) and
most of the current evidence on intranasal OT’s psychological
effects, which support the current hypotheses, come from stud-
ies with exclusively male samples. A separate analysis of fe-
male participants, controlling for a series of additional variables
related to natural variations in OT (MacDonald, 2012), is
ongoing.
A total of 83 mid-life men took part in the study (MAge¼ 45.1,
s.d.Age¼ 8) in return for $120 in compensation. The majority of
participants self-identified as White/Caucasian (86.7%), and the
remaining participants were Black/African American (7.2%), or
Asian (4.8%), one participant did not report race; additionally,
7.2% of the entire sample identified as being ethnically
Hispanic. Participants were Christian (50.6%), Muslim (1.2%),
Buddhist (2.4%), Jewish (2.4%), Agnostic (19.3%), Atheist (19.3%)
or other (4.8%).
Participants were randomly assigned to one of two condi-
tions: OT (N¼ 41) or placebo (N¼ 42). All received a nasal spray
containing either Syntocinon (24 IU) or a placebo, which con-
tained all ingredients except active OT. Under the experi-
menter’s supervision, participants self-administered three full
sprays into each nostril, alternating nostrils each time for a total
of six sprays. Syntocinon was purchased from the
Internationale Apotheke, a Swiss international pharmacy, and
bottled for single use by the Triangle Compounding Pharmacy,
North Carolina. OT and placebo doses were administered from
identical blind-labeled spray vials and had the same color, smell
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and pH. Participants, the experimenter and the research staff
were blind to experimental condition, which was revealed only
once data collection was complete. Experimenters were all thor-
oughly trained to behave in a professional and neutral way with
participants. After the administration of OT or placebo, all par-
ticipants provided a saliva sample for genotyping. Effects of OT
typically emerge after 30–40min (e.g. Israel et al., 2014); there-
fore, approximately 40min after the nasal spray, participants
first completed questionnaires assessing spirituality. Then, par-
ticipants were invited to follow a 20 min guided meditation.1
Implicit and explicit measures of emotions felt as a result of
and during meditation directly followed. A week later, partici-
pants (N¼ 81) completed a follow-up measure of spirituality as
part of a larger online questionnaire.
Measures
Spirituality. We assessed spirituality through two self-report
measures: a single-item assessment of spirituality (a measure
devoid of any investigator-established conception of spiritual-
ity, allowing participants to project their own definition of spir-
ituality) and a validated and widely used scale of spirituality
[Spiritual Transcendence Scale (STS); Piedmont, 1999]. First, we
administered the one-item measure of state spirituality: ‘Right
now, would you say that spirituality is important in your life?’
Participants responded using a 8-point Likert type scale (0¼not
at all; 7¼ completely; Van Cappellen et al., 2013). This measure
was repeated again 1 week after the laboratory session as part
of a larger online questionnaire. Second, we administered the
STS (Piedmont, 1999). In creating this scale, Piedmont (1999)
defined spirituality as the tendency to orient oneself toward a
larger transcendent reality that binds all things into a unitive
harmony. It reflects the personal search for connection with a
larger sacredness. The subscale Prayer Fulfillment was not
included in this study because this measure of spirituality is not
clearly distinct from religiosity. Indeed, it has an explicitly reli-
gious content (reference to God and religious practices such as
prayer) and has been found to relate positively to traditional re-
ligious attitudes and behaviors (Piedmont, 1999). Reliability for
the items included was satisfactory (a¼ 0.86).
Emotions as a result of meditation. Right after the 20 min guided
meditation, participants completed an adaptation of the
Implicit Positive and Negative Affect Test (Quirin et al., 2009).
Participants were instructed that they would see a list of words
(a total of six words) from an artificial language and that these
words (e.g. safme) are intended to express various moods. Then,
they were asked to rate the extent to which the word conveys
each of the following emotions: happy, relaxed, loving, helpless
and sad. We chose these emotion words for their relevance to
positive or negative experiences during meditation. Participants
were asked to let themselves be guided by their spontaneous
feelings in making these ratings. Past research has shown that
participants tend to rate these artificial words according to how
they currently feel (Quirin et al., 2009). Participants responded
using a Likert-type scale (1¼does not fit at all, 2¼ fits some-
what, 3¼ fits quite well, 4¼ fits very well). Mean scores are com-
puted across the six artificial words for the three positive
emotions and separately for the two negative emotions.
Reliability was satisfactory for both the positive and negative
emotions scores (respectively, a¼ 0.82, a¼ 0.72). We also used
an explicit measure of emotional experience, the ‘modified
Differential Emotions Scale’ (Fredrickson, 2013), which assesses
10 different positive emotions (amusement, awe, gratitude,
hope, inspiration, interest, joy, love, pride and serenity) and 10
negative emotions (anger, shame, contempt, disgust, embar-
rassment, guilt, hate, sadness, fear and stress). Participants
were asked to rate the extent to which they felt each emotion
during the guided meditation and respond on a Likert-type scale
(0¼not at all, 1¼hardly, 2¼ some of the time, 3¼often,
4¼most of the time). Mean scores were computed for positive
emotions (a¼ 0.91), negative emotions (a¼ 0.82) and self-
transcendent positive emotions (awe, gratitude, inspiration and
love; a¼ 0.87).
Involvement in organized religion. Participants provided their reli-
gious affiliation at the time of registering for the study. We
coded their answers to correspond to 1¼ affiliated with a reli-
gion, 2¼not affiliated with a religion (i.e. agnostics and athe-
ists). Four participants had responded ‘other’ without specifying
it further and were thus excluded through list-wise deletion for
the analyses including this variable. Given the specific focus in
the present study on spirituality and given that involvement in
organized religion is strongly correlated with spirituality (Marler
and Hadaway, 2002), we used this variable as a covariate in all
analyses for which spirituality was an outcome. This approach
is also in keeping with past experimental research that tested
the causal role of positive emotions on spirituality and found
that having a religious affiliation moderated the primary effect
(Van Cappellen et al., 2013). More information is provided in
Supplementary Data available online.
DNA extraction and genotyping
All participants provided a saliva sample by passive drool into a
15 ml centrifuge tube right after the OT/placebo administration.
Samples were frozen within 5 min. Samples were thawed and
DNA was extracted using Qiagen QIAamp DNA Mini Kit accord-
ing to manufacturer’s instructions. Samples were genotyped
using Taqman single nucleotide polymorphism (SNP)
Genotyping Assays (Applied Biosystems, Inc) according to the
standard protocol provided with the kit. Polymerase chain reac-
tions were performed using 20 ml reaction volumes in 96-well
plates with 25ng of DNA. End point reads of fluorescence levels
were obtained with an Applied Biosystems Incorporated 7300HT
Sequence Detection System. For quality control, 26% of
rs6449182 genotypes, 4% of rs3796863 genotypes and 18% of
rs53576 genotypes were re-run and showed perfect concord-
ance. Haploview (version 4.2; Barrett et al., 2005) was used to cal-
culate Hardy–Weinberg Equilibrium values using the exact test
(Wigginton et al., 2005). The distribution of genotypes did not de-
viate from Hardy-Weinberg equilibrium (all P’s> 0.250). For
rs53576, genotyping was unsuccessful for two participants, one
in the placebo condition and one in the OT condition. For
rs6449182, genotyping was unsuccessful for two participants,
one in the placebo condition and one in the OT condition.
Genes were coded in the following fashion: CD38 rs3796863
was coded in a dominant manner, AA/AC¼ 0, CC¼ 1, following
Feldman et al. (2012); CD38 rs6449182 was coded in a co-
dominant way CC¼ 0, CG¼ 1, GG¼ 2, following Algoe and Way
(2014); see Supplementary Data available online for alternative
coding and tests. OXTR rs53576 was coded in a dominant way,
GG¼ 0, GA/AA¼ 1, consistent with a meta-analysis of this
marker (Bakermans-Kranenburg and van IJzendoorn, 2014).
1 Participants were randomly assigned to either a Mindfulness or a
Loving-Kindness meditation but given that meditation type did not
interact with OT, these two types will not be further discussed.
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Numbers of participants for each genotype by condition are pro-
vided in Table S1 in the Supplementary Data available online.
Analyses
All analyses were performed with SPSS v.23. Conditions were
dummy coded, Placebo¼ 0, OT¼ 1. For models including spiritu-
ality variables, we conducted one-way analyses of covariance
(ANCOVAs), controlling for a variable that is distinct although
strongly correlated with spirituality, religious affiliation. See
Supplementary Data available online for additional discussion
of this confounding variable and tests for assumptions of
ANCOVAs. For the other models, we ran one-way analyses of
variance (ANOVAs). These analyses included a total of eight
tests and were corrected for multiple comparisons using a false
discovery rate (FDR) (Benjamini and Hochberg, 1995) of 0.05. In
Table 1, we provide raw P-values and FDR adjusted P-values.
See Table S3 in Supplementary Data available online for FDR per
test. Two-way ANOVAS were used to test for effects of condi-
tions, genotype and their interactions. Post hoc contrasts were
run using ANOVAs. We report exact P-values using two-tailed
tests.
Results
At the end of the lab session, participants indicated whether
they thought they received OT or a placebo, or whether they
really did not know. Sixty-two percent of participants re-
sponded that they did not know. Among participants who re-
sponded that they had taken one treatment over another, a chi-
square test of independence was performed to examine
whether actual treatment predicted participants’ perceived
treatment. This test was not significant, v2 (1, N¼ 31)¼ 1.55,
P¼ 0.213.
Participants in both groups were similar on a series of rele-
vant baseline measures (i.e. emotions, mindfulness and reli-
gious affiliation). See Supplementary Data available online for
full results.
Intranasal OT’s effects
Spirituality-related outcomes. Means, standard deviations as well
as mean differences tests are detailed in Table 1. The one-item
measure of spirituality taken in lab and the STS were positively
correlated (r¼ 0.75, P< 0.001), see Table S2 in Supplementary
Data available online for full correlation matrix of dependent
variables. Results show that compared to participants in the
placebo condition, participants in the OT condition reported
greater spirituality during the lab session (on both spirituality
scales) and 1 week later. These effects remained significant
when controlling for baseline positive and negative emotions
and for dispositional mindfulness (see Supplementary Data
available online).
We also ran additional analyses on the STS to better under-
stand which items were affected by OT. First, we computed a
new mean score excluding three items of the STS that include
notions of death and contact with deceased people, which are
less typical spiritual beliefs. Removing these items did not
change the pattern of results (OT: M¼ 5.26, SE¼ 0.1; Placebo:
M¼ 4.85, SE¼ 0.1, F(2,75)¼ 4.40, P¼ 0.039, gp2¼ 0.055, mean dif-
ference¼0.41, 95% CI [0.80, 0.02], d¼0.35). Then, to better
disentangle between the aspects of connection and of meaning
in the STS, we computed two scores, one including all items
related to interconnectedness (i.e. ‘I feel that on a higher level
all of us share a common bond’; ‘All life is interconnected’;
‘There is a higher plane of consciousness or spirituality that
binds all people’; ‘Although individual people may be difficult, I
feel an emotional bond with all of humanity’; ‘I believe that on
some level my life is intimately tied to all of humankind’) and
one including all items related to meaning and purpose (i.e. ‘I
believe that there is a larger meaning to life’; ‘I believe there is a
larger plan to life’; ‘There is an order to the universe that tran-
scends human thinking’). Results reveal that OT increased par-
ticipants’ level on STS interconnectedness (OT: M¼ 5.24,
SE¼ 0.2; Placebo: M¼ 4.77, SE¼ 0.2, F(2,75)¼ 3.79, P¼ 0.055,
gp
2¼ 0.048, mean difference¼0.47, 95% CI [0.94, 0.01],
d¼0.37) and on STS meaning and purpose (OT: M¼ 5.10,
SE¼ 0.2; Placebo: M¼ 4.37, SE¼ 0.2, F(2,75)¼ 6.19, P¼ 0.015,
gp
2¼ 0.076, mean difference¼0.74, 95% CI [1.33, 0.15],
d¼0.33).
Emotion outcomes. Means, standard deviations as well as mean
differences tests are detailed in Table 1. For positive emotions,
self-reported and implicit measures were positively correlated
(r¼ 0.45, P< 0.001). This was not the case for negative emotions
(r¼ 0.12, P> 0.250). Results show that compared to participants
in the placebo condition, participants in the OT condition re-
ported greater implicit positive emotions following meditation,
and greater explicit retrospective reports of self-transcendent
positive emotions during meditation. These effects remained
significant when controlling for baseline positive and nega-
tive emotions and for dispositional mindfulness (see
Supplementary Data available online).
Table 1. Means, standard deviations and between-conditions comparisons of all the dependent variables
Conditions
Variables Placebo OT Mean difference
95% CI
d gp
2 F P P(FDR)
M (SE) M (SE)
Spiritual Transcendence Scalea 4.71 (0.1) 5.08 (0.1) [0.81, 0.05] 0.36 0.063 (2, 75) ¼ 5.03 0.028 0.048
Spirituality—1 item—Laba 3.08 (0.3) 4.02 (0.3) [1.78, 0.09] 0.26 0.061 (2, 75) ¼ 4.87 0.030 0.048
Spirituality—1 item—1Week Follow Upa 3.08 (0.3) 4.13 (0.3) [1.85, 0.24] 0.30 0.083 (2, 74) ¼ 6.72 0.011 0.040
Implicit Positive Emotions 1.89 (0.1) 2.13 (0.1) [0.43, 0.05] 0.55 0.070 (1, 81) ¼ 6.14 0.015 0.040
Explicit Positive Emotions 1.73 (0.1) 2.03 (0.1) [0.61, 0.02] 0.42 0.041 (1, 81) ¼ 3.48 0.066 0.088
Explicit Self-transcendent Positive Emotions 1.53 (0.1) 2.03 (0.1) [0.88, 0.12] 0.58 0.078 (1, 81) ¼ 6.87 0.010 0.040
Implicit Negative Emotions 1.60 (0.1) 1.62 (0.1) [0.20, 0.17] 0.05 0.000 (1, 81) ¼ 0.03 0.866 0.866
Explicit Negative Emotions 0.22 (0.1) 0.34 (0.1) [0.27, 0.05] 0.33 0.024 (1, 81) ¼ 1.96 0.165 0.189
aControlling for whether participants are religiously affiliated. P(FDR)¼False discovery rate adjusted P-values (Benjamini and Hochberg, 1995).
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Mediation tests. Given that participants in the OT condition re-
ported increased spirituality and positive emotions derived
from meditation, we tested whether the increase in spirituality
partially accounted for the subsequent increase in positive emo-
tions related to meditation. We ran bootstrapped mediation
analyses using the PROCESS macro for SPSS, model 4, 5000 sam-
ples (Hayes, 2013). Religious affiliation was used as a covariate
for the mediator (spirituality measures) only. In Table 2, for
each model tested, we report data parameters and bias cor-
rected 95% confidence intervals of the indirect effect and the
direct effect of conditions on the outcome once the mediator is
taken into account. Results show that spirituality (one-item
measure and STS) mediated the relation between conditions
and the positive emotions felt during or as a result of medita-
tion at both the implicit and explicit levels****.
Exploratory analyses of genetic moderation
Interaction effects
Analyses were run using each SNP individually. Interaction ef-
fects are detailed in Table 3.
CD38 rs3796863. Interaction tests were significant for the one-
item measure of spirituality at lab session. Post hoc contrasts re-
vealed that A carriers (AA/AC) showed a significant increase on
this measure in the OT condition (M¼ 4.46, SE¼ 0.40) compared
to the Placebo condition (M¼ 2.54, SE¼ 0.40), F(2, 35)¼ 11.03,
P¼ 0.002, gp2¼ 0.240, mean difference¼1.92, 95% CI [3.09,
0.74], d¼0.55. For CC homozygotes, there was no significant
difference between OT and placebo conditions (P> 0.250). There
was also a significant interaction for the STS. Post hoc contrasts
revealed that again A carriers (AA/AC) showed a significant in-
crease on this measure in the OT condition (M¼ 5.31, SE¼ 0.18)
compared to the Placebo condition (M¼ 4.55, SE¼ 0.18), F(2,
35)¼ 8.45, P¼ 0.006, gp2¼ 0.194, mean difference¼0.76, 95% CI
[1.29, 0.23], d¼0.80. For CC homozygotes, there was no sig-
nificant difference between OT and placebo conditions
(P> 0.250). Finally, there was a marginally significant inter-
action for the one-itemmeasure of spirituality at the 1 week fol-
low up. Post hoc contrasts revealed that A carriers (AA/AC)
showed a significant increase on this measure in the OT condi-
tion (M¼ 4.32, SE¼ 0.40) compared to the Placebo condition
(M¼ 2.72, SE¼ 0.41), F(2, 34)¼ 7.38, P¼ 0.010, gp2¼ 0.178, mean
difference¼1.60, 95% CI [2.80, 0.40], d¼0.41. For CC
homozygotes, there was no significant difference between OT
and placebo conditions (P> 0.250).
CD38 rs6449182. Interaction tests were significant for the one-
item measure of spirituality at lab session. Post hoc contrasts re-
vealed that CC homozygotes showed a significant increase on
this measure in the OT condition (M¼ 4.32, SE¼ 0.38) compared
to the Placebo condition (M¼ 2.78, SE¼ 0.55), F(2, 41)¼ 8.70,
P¼ 0.005, gp2¼ 0.175, mean difference¼1.56, 95% CI [2.63,
0.49], d¼0.60. For CG and GG genotypes, there was no
Table 2. Mediation analyses: conditions predicting positive emotions related to meditation as a result of spirituality
Indirect effect c’ path
Outcome Mediator PE SE 95% BC CI PE SE 95% BC CI
Implicit Positive Emotions Spiritual Transcendence Scale 0.05 0.03 [0.01, 0.14] 0.20 0.10 [0.002, 0.39]
Spirituality—1 item—Lab 0.06 0.03 [0.01, 0.14] 0.20 0.10 [0.01, 0.39]
Explicit Positive Emotions Spiritual Transcendence Scale 0.12 0.07 [0.02, 0.30] 0.18 0.16 [0.14, 0.50]
Spirituality—1 item—Lab 0.10 0.06 [0.02, 0.26] 0.21 0.16 [0.11, 0.53]
Explicit Self-transcendent Positive Emotions Spiritual Transcendence Scale 0.16 0.09 [0.03, 0.38] 0.35 0.19 [0.03, 0.72]
Spirituality—1 item—Lab 0.14 0.08 [0.03, 0.34] 0.38 0.19 [0.01, 0.76]
Notes: 5000 bootstrap samples. PE stands for point estimate. 95% BC CI stands for 95% Bias Corrected Confidence Interval. Covariate included for mediator only (con-
trolling for whether participants are religiously affiliated).
Table 3. Summary of results for condition predicting spirituality-
related measures as moderated by variations of CD38 and OXTR
Variables Main effects and interaction
gp
2 F P
Spirituality—1 item—Lab
CD38 rs3796863 0.000 (4,73) ¼ 0.001 0.980
Conditions 0.137 (4,73) ¼ 11.63** 0.001
Interaction 0.081 (4,73) ¼ 6.47* 0.013
CD38 rs6449182 0.004 (4,72) ¼ 0.30 0.583
Conditions 0.116 (4,72) ¼ 9.43** 0.004
Interaction 0.063 (4,72) ¼ 4.88* 0.030
OXTR rs53576 0.001 (4,72) ¼ 0.05 0.823
Conditions 0.015 (4,72) ¼ 1.08 0.302
Interaction 0.004 (4,72) ¼ 0.30 0.583
Spirituality—1 item—Week 1
CD38 rs3796863 0.000 (4,72) ¼ 0.10 0.922
Conditions 0.116 (4,72) ¼ 9.46** 0.003
Interaction 0.042 (4,72) ¼ 3.12† 0.082
CD38 rs6449182 0.004 (4,70) ¼ 0.31 0.582
Conditions 0.108 (4,70) ¼ 8.47** 0.005
Interaction 0.042 (4,70) ¼ 3.03† 0.086
OXTR rs53576 0.001 (4,70) ¼ 0.05 0.826
Conditions 0.005 (4,70) ¼ 0.35 0.555
Interaction 0.025 (4,70) ¼ 1.82 0.182
Spiritual Transcendence Scale
CD38 rs3796863 0.001 (4,73) ¼ 0.06 0.815
Conditions 0.130 (4,73) ¼ 10.96** 0.001
Interaction 0.072 (4,73) ¼ 5.70* 0.020
CD38 rs6449182 0.009 (4,72) ¼ 0.62 0.434
Conditions 0.098 (4,72) ¼ 7.83** 0.007
Interaction 0.044 (4,72) ¼ 3.31† 0.073
OXTR rs53576 0.006 (4,72) ¼ 0.46 0.499
Conditions 0.000 (4,72) ¼ 0.00 0.989
Interaction 0.049 (4,72) ¼ 3.68† 0.059
Note: Controlling for whether participants are religiously affiliated.
**P< 0.01,
*P<0.05,
†P<0.10.
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significant difference between OT and placebo conditions (all
P’s> 0.250). There was also a marginally significant interaction
for the STS. Post hoc contrasts revealed that again CC homozy-
gotes showed a significant increase on this measure in the OT
condition (M¼ 5.25, SE¼ 0.15) compared to the Placebo condi-
tion (M¼ 4.59, SE¼ 0.14), F(2, 41)¼ 10.62, P¼ 0.002, gp2¼ 0.206,
mean difference¼0.66, 95% CI [1.07, 0.25], d¼0.72. For CG
and GG genotypes, there was no significant difference between
OT and placebo conditions (all P’s> 0.250). Finally, there was a
marginally significant interaction for the one-item measure of
spirituality at the 1 week follow up. Post hoc contrasts revealed
that again CC homozygotes showed a significant increase on
this measure in the OT condition (M¼ 4.43, SE¼ 0.38) compared
to the Placebo condition (M¼ 3.00, SE¼ 0.37), F(2, 40)¼ 7.18,
P¼ 0.011, gp2¼ 0.152, mean difference¼1.43, 95% CI [2.51,
0.35], d¼0.56. For the CG genotype, there was no significant
difference between OT and placebo conditions (P> 0.250), and
for GG homozygotes a marginal difference in the opposite direc-
tion such that they had lower scores on this measures in the OT
condition (M¼ 2.34, SE¼ 0.27) compared to the Placebo condi-
tion (M¼ 3.77, SE¼ 0.22), F(2, 2)¼ 16.67, P¼ 0.055, gp2¼ 0.893,
mean difference¼ 1.43, 95% CI [0.08, 2.93], d¼ 1.20.
There were no significant interactions between condition
and either SNP regarding emotions felt as a result of or during
meditation across either the implicit and explicit measures (all
P’s> 0.143).
OXTR rs53576. Although there was no interaction between con-
dition and rs53576 with respect to the one-item measures of
spirituality, there was a marginally significant interaction with
respect to the STS (Table 3). Post hoc contrasts revealed that A
carriers (AG/AA) showed a significant increase on the STS in the
OT condition (M¼ 5.32, SE¼ 0.17) compared to the Placebo con-
dition (M¼ 4.58, SE¼ 0.19), F(2, 38)¼ 8.40, P¼ 0.006, gp2¼ 0.181,
mean difference¼0.74, 95% CI [1.25, 0.22], d¼0.85. For GG
homozygotes, there was no significant difference between OT
and placebo conditions (P> 0.250). As for the variants in CD38,
no significant interactions emerged regarding emotions felt as a
result of or during meditation across either the implicit and ex-
plicit measures (all P’s> 0.250).
Discussion
Compared to a placebo, administration of OT increased male
participants’ levels of self-reported spirituality using two dis-
tinct measures. This effect remained significant a week later.
Intranasal OT also increased specific positive emotions derived
from meditation, an activity commonly practiced by spiritual
people, as reflected in both implicit and explicit assessments.
These results held after adjusting for the FDR (Benjamini and
Hochberg, 1995).
These findings build on prior evidence of correlations be-
tween measures of endogenous OT with ratings of spirituality
(Kelsch et al., 2013; Holbrook et al., 2015) in two ways. First, the
experimental design employed here takes a step toward estab-
lishing causality and provides information on the direction of
causality by showing that, at least among men, elevations in OT
lead to increases in spirituality. Future experimental research
will be necessary to determine whether the other direction of
causality—i.e. whether spirituality (beliefs and/or practices) can
increase OT—is also possible. Second, the relationship between
peripheral measures of OT, whether assayed in the blood or sal-
iva, to OT levels in the brain is unclear (Kagerbauer et al., 2013).
In contrast, evidence suggests that intranasal administration of
OT increases OT levels in the brain (Striepens et al., 2013; and in
animal research, Dal Monte et al., 2014; Modi et al., 2014). As
such, the data presented here suggest that central OT is in fact
driving the increase in spirituality.
Having established a link between OT and spirituality, the
next question concerns the psychological processes underlying
this phenomenon. We speculate that the effects of OT on social
affiliation account for the current findings, although direct test-
ing of this speculation awaits future research. Additional ana-
lyses revealed that OT also impacted items of the STS beyond
those related to interconnectedness, specifically those targeting
belief in larger meaning and purpose in life. Future research
should unpack the distinct concepts embedded within defin-
itions of spirituality, aspects that can also be studied separately
from the larger construct of spirituality. OT also impacted spe-
cific positive emotions participants derived from an initiation to
meditation. One potential explanation for this effect, supported
by the data, is that the boost in spirituality evident among those
in the OT condition led participants to experience more in-
tensely the accompanying positive emotions. OT did not impact
negative emotions felt during or as a result of the meditation,
which may be attributable to a floor effect. Additionally, meas-
ures of positive and negative emotions were uncorrelated in
this study (self-reported positive and negative emotions,
r¼0.04, P> 0.250; implicit positivity and negativity, r¼ 0.08,
P> 0.250), in keeping with a wide range of evidence that positive
and negative affective states are independent dimensions of
human experience (e.g. Watson et al., 1988; Fredrickson et al.,
2008). Finally, the finding that OT still impacted spirituality a
week after the administration merits further research to better
understand the underlying mechanisms of action. Although
long-term effects of OT have not been reported in past litera-
ture, to our knowledge they may not have been directly tested
(exceptions include studies on ‘repeated’ OT administration
over several days in clinical samples; e.g. Epperson et al., 1996;
Guastella et al., 2010). Turning to psychological interpretations,
one possibility is that OT administration increased the enjoy-
ment of spirituality-related activities over that week and/or the
frequency of self-transcendent positive emotions, each of
which have been shown to promote spirituality (Van Cappellen
and Saroglou, 2012; Van Cappellen et al., 2013).
Our exploratory analyses of polymorphisms in the OT sys-
tem suggest that genetic variation moderates the effects of
intranasal OT administration. Because OT can bind to non-OT
receptors, for example vasopressin receptors (Gimpl and
Fahrenholz, 2001), behavioral effects of OT administration could
possibly be a result of these effects. However, the genetic vari-
ants moderating the effects of intranasal OT that we studied are
in the OT system, which supports the inference that the
observed effects of administered OT on spirituality are indeed
due to action within the OT system.
Themost robust effects on spirituality were found for the vari-
ants in CD38. That polymorphisms located in two different re-
gions of the CD38 gene each moderated the effect provides
convergent validity for the involvement of CD38 in moderating
the effects of intranasal OT. The genotypes most responsive to
intranasal OT (rs3796863: A carriers, AA/AC; rs6449182: CC) were
each associated with higher levels of CD38 expression in immor-
talized cell lines generated from blood cells (Lerer et al., 2010;
Riebold et al., 2011). Although these measures are based on in vitro
assessment of expression in peripheral tissue and should thus be
interpreted with caution (e.g. Jamroziak et al., 2009), this could in-
dicate that greater responses to OT administration in these indi-
viduals are due to greater expression of CD38. How this
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differential expression could impact OT signaling is not clear.
One hypothesis is that because CD38 is critical for the release of
OT from neurons, this differential expression affects OT release.
One potential mechanism accounting for this would arise from
the unique property of OT neurons: their ability to autoregulate.
OT neurons express the OT receptor on their dendrites (Freund-
Mercier et al., 1994). Activation of this dendritically located OT re-
ceptor initiates an intracellular signaling cascade that can lead to
either the actual release of OT from the dendrites or the priming
of this release (Tobin et al., 2012). Once activated, this positive
feedback loop can lead to an enduring, self-sustaining release of
OT. Because CD38 is a critical intermediary of the intracellular
signaling cascade between binding of the dendritic OT receptor
and OT release from the dendrites (Salmina et al., 2013), gene vari-
ants affecting expression of CD38 may impact this process.
Naturally, with the nascent understanding of how these variants
affect oxytocinergic signaling, such a hypothesis should be
viewed as speculative as should any links between this autoregu-
latory capacity of oxytocinergic neurons and psychological
changes in response to OT administration.
The most commonly studied polymorphism of OXTR
(rs53576) also moderated the effects of intranasal OT on one of
the three measures of spirituality. The A allele carriers were the
most responsive to the OT manipulation. We note that prior lit-
erature has found that the GG genotype is more responsive to
either exogenous (Marsh et al., 2012; Feng et al., 2015) or en-
dogenous OT (Moons et al., 2014) so the present findings should
be considered preliminary. Taken together, these findings indi-
cate that there are individual differences in the OT system that
impact the response to intranasal OT.
In the present study, consistent with other research on spir-
ituality (Van Cappellen et al., 2013), we found that controlling for
one aspect culture, i.e. involvement in organized religion, was
critical to observing the effects of exogenous OT on spirituality
(see Saroglou and Cohen, 2013 for a discussion on religion as a
cultural system). Religion, or the belief in a Higher Power in a
structured way, is related yet distinct from spirituality. Here, we
found that when controlling for this confounding variable, OT
administration increased all participants’ level of spirituality.
However, additional analyses (described in the Supplementary
Data available online) revealed that this effect is more evident
among participants who are not affiliated with an organized re-
ligion, potentially because they tend to score lower on measures
of spirituality (see similar findings in Van Cappellen et al., 2013).
Future research may investigate whether other cultural aspects
moderate the psychological outcomes of the OT system (e.g.
Kim et al., 2011).
Intriguingly, recent empirical developments have uncovered
a host of psychological effects of OT that are strikingly similar
to those of spiritual beliefs and practices. Although context and
individual differences qualify the effects of OT and of spiritual-
ity, they have both generally been related, in separate research
literatures, to social affiliation and prosociality (at least to some
extent, MacDonald and MacDonald, 2010; Saroglou, 2012) as
well as to physical and mental health (OT: Striepens et al., 2011;
Spirituality: Koenig et al., 2012; Positive emotions derived from
meditation: Fredrickson, 2013; Van Cappellen et al., 2016).
Finding that OT can increase spirituality and specific positive
emotions derived from practicing meditation allows the gener-
ation of new hypotheses on mediating processes. For example,
given the evidence that spirituality and the enjoyment of medi-
tation are related to health, the data presented here suggest
that they both may represent sustained mechanisms through
which OTmay impact health.
Because several different neurotransmitters have been
implicated in spirituality (McNamara and Butler, 2013), we do
not consider OT to be ‘the spiritual hormone’. Spiritual beliefs
and related practices represent complex phenomena that are
shaped by complex and multidimensional processes. However,
growing evidence (e.g. Gervais, 2013), including the data pre-
sented here, suggests that humans—and perhaps some more
than others—are biologically and cognitively predisposed to be
receptive to spiritual experiences.
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